Fda update on mobile phone safety – Siemens S40 User Manual

Page 46

Advertising
background image

89

FDA Update on mobile phone safety

88

In summary, we do not have

enough information at this point to

assure the public that there are, or

are not, any low incident health

problems associated with use of

mobile phones.

FDA continues to work with all

parties, including other federal

agencies and industry, to assure

that research is undertaken to pro-

vide the necessary answers to the

outstanding questions about the

safety of mobile phones.

What is known about cases of

human cancer that have been

reported in users of hand-held

mobile phones?

Some people who have used

mobile phones have been diag-

nosed with brain cancer. But it is

important to understand that this

type of cancer also occurs among

people who have not used mobile

phones.

In fact, brain cancer occurs in the

U.S. population at a rate of about 6

new cases per 100,000 people

each year. At that rate, assuming

80 million users of mobile phones

(a number increasing at a rate of

about 1 million per month), about

4800 cases of brain cancer would

be expected each year among

those 80 million people, whether or

not they used their phones.

Thus it is not possible to tell

whether any individual’s cancer

arose because of the phone, or

whether it would have happened

anyway. A key question is whether

the risk of getting a particular form

of cancer is greater among people

who use mobile phones than

among the rest of the population.

One way to answer that question

is to compare the usage of mobile

phones among people with brain

cancer with the use of mobile

phones among appropriately

matched people without brain can-

cer. This is called a case-control

study.

The current case-control study of

brain cancers by the National

Cancer Institute, as well as the fol-

low-up research to be sponsored

by industry, will begin to generate

this type of information.

What is FDA’s role concerning

the safety of mobile phones?

Under the law, FDA does not

review the safety of radiation-emit-

ting consumer products such as

mobile phones before marketing,

as it does with new drugs or med-

ical devices.

However, the agency has authori-

ty to take action if mobile phones

are shown to emit radiation at a

level that is hazardous to the user.

In such a case, FDA could require

the manufacturers of mobile

phones to notify users of the

health hazard and to repair, replace

or recall the phones so that the

hazard no longer exists.

Although the existing scientific data

do not justify FDA regulatory

actions at this time, FDA has urged

the mobile phone industry to take a

Most cancer causing agents

increase

risk with increased expo-

sure. An ongoing study of brain

cancers by the National Cancer

Institute is expected to bear on the

accuracy and repeatability of these

results. 1)

• Researchers conducted a large

battery of laboratory tests to

assess the effects of exposure to

mobile phone RF on genetic mate-

rial. These included tests for sever-

al kinds of abnormalities, including

mutations, chromosomal aberra-

tions, DNA strand breaks, and

structural changes in the genetic

material of blood cells called lym-

phocytes.

None of the tests showed any

effect of the RF except for the

micronucleous assay, which

detects structural effects on the

genetic material. The cells in this

assay showed changes after expo-

sure to simulated cell phone radia-

tion, but only after 24 hours of

exposure. It is possible that expos-

ing the test cells to radiation for

this long resulted in heating.

Since this assay is known to be

sensitive to heating, heat alone

could have caused the abnormali-

ties to occur. The data already in

the literature on the response of

the micronucleus assay to RF are

conflicting. Thus follow-up research

is necessary. 2)

FDA is currently working with

government, industry, and academ-

ic groups to ensure the proper fol-

low-up to these industry-funded

research findings.

Collaboration with the Cellular

Telecommunications Industry

Association (CTIA) in particular is

expected to lead to FDA providing

research recommendations and sci-

entific oversight of new CTIA-fund-

ed research based on such recom-

mendations.

Two other studies of interest

have been reported recently in the

literature:

• Two groups of 18 people were

exposed to simulated mobile

phone signals under laboratory con-

ditions while they performed cogni-

tive function tests. There were no

changes in the subjects’ ability to

recall words, numbers, or pictures,

or in their spatial memory, but they

were able to make choices more

quickly in one visual test when

they were exposed to simulated

mobile phone signals. This was the

only change noted among more

than 20 variables compared. 3)

• In a study of 209 brain tumor

cases and 425 matched controls,

there was no increased risk of

brain tumors associated with

mobile phone use. When tumors

did exist in certain locations, how-

ever, they were more likely to be

on the side of the head where the

mobile phone was used. Because

this occurred in only a small num-

ber of cases, the increased likeli-

hood was too small to be statisti-

cally significant. 4)

Further information

User guide S40 US 11/01/01 9:30 Side 88

Advertising